Connection
Hannah Robinson to Cetuximab
This is a "connection" page, showing publications Hannah Robinson has written about Cetuximab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.201 |
|
|
|
-
Robinson HR, Lieu CH. Anti-EGFR Therapy for Left-Sided RAS Wild-type Colorectal Cancer-PARADIGM Shift. JAMA Oncol. 2023 06 01; 9(6):767-769.
Score: 0.201